1. Arf6 and its ZEB1-EPB41L5 mesenchymal axis are required for both mesenchymal- and amoeboid-type invasion of cancer cells. (3rd September 2018) Authors: Handa, Haruka; Hashimoto, Ari; Hashimoto, Shigeru; Sabe, Hisataka Journal: Small GTPases Issue: Volume 9:Number 5(2018) Page Start: 420 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Endothelin type B receptor interacts with the 78‐kDa glucose‐regulated protein. Issue 6 (5th March 2019) Authors: Mazaki, Yuichi; Higashi, Tsunehito; Onodera, Yasuhito; Nam, Jin‐Min; Hashimoto, Ari; Hashimoto, Shigeru; Horinouchi, Takahiro; Miwa, Soichi Journal: FEBS letters Issue: Volume 593:Issue 6(2019) Page Start: 644 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. High expression of EPB41L5, an integral component of the Arf6-driven mesenchymal program, correlates with poor prognosis of squamous cell carcinoma of the tongue. Issue 1 (December 2016) Authors: Otsuka, Yutaro; Sato, Hiroki; Oikawa, Tsukasa; Onodera, Yasuhito; Nam, Jin-Min; Hashimoto, Ari; Fukunaga, Kiyoshi; Hatanaka, Kanako; Hatanaka, Yutaka; Matsuno, Yoshihiro; Fukuda, Satoshi; Sabe, Hisataka Journal: Cell communication and signaling Issue: Volume 14:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Tumor responsiveness to statins requires overexpression of the ARF6 pathway. (3rd July 2016) Authors: Sabe, Hisataka; Hashimoto, Ari; Hashimoto, Shigeru; Oikawa, Tsukasa Journal: Molecular & cellular oncology Issue: Volume 3:Number 4(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗